LQDA
Liquidia Technologies Inc
NASDAQ: LQDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$38.15
+1.33% today
Updated 2026-04-29
Market cap
$3.39B
P/E ratio
—
P/S ratio
21.42x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$12 – $47
Volume
1.4M
Liquidia Technologies Inc (LQDA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.95M | $-24.29M | $-31.83M | $-48.28M | $-54.14M | $-34.03M | $-28.59M | $-41.56M | $-93.42M | $-35.69M |
| Capital expenditures | $2.89M | $2.54M | $870943.00 | $1.85M | $752086.00 | $107000.00 | $592000.00 | $1.29M | $4.95M | $4.34M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $347444.00 | $514092.00 | $2.20M | $3.38M | $3.95M | $6.75M | $9.30M | $10.09M | $18.81M | $29.47M |
| Free cash flow | $-16.83M | $-26.83M | $-32.70M | $-50.13M | $-54.90M | $-34.14M | $-29.18M | $-42.85M | $-98.37M | $-40.02M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $16.26M | — | — | — | — | — | — |